Capricor Therapeutics | CAPR - Assets


Capricor Therapeutics reported $355.95M in Assets for its fiscal quarter ending in December of 2025.





Assets Change Date
Alterity Therapeutics Limited AUD 37.98M 15.78M Dec/2025
Bioline Rx USD 39.8M 3.47M Sep/2025
Capricor Therapeutics USD 355.95M 229.51M Dec/2025
Cipla INR 401.64B 27.77B Sep/2025
Cytokinetics USD 1.27B 151.06M Mar/2026
Geron USD 570.54M 3.16M Dec/2025
Grifols EUR 23.15B 142.7M Dec/2025
Immunic USD 24.05M 16.65M Dec/2025
J&J USD 200.89B 1.68B Mar/2026
Plus Therapeutics USD 16.32M 2.34M Dec/2025
Prothena USD 326.8M 25.82M Dec/2025
PTC Therapeutics USD 2.9B 255.07M Dec/2025
Sarepta Therapeutics USD 3.35B 143.73M Dec/2025